Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) - Cash Flow Conversion Efficiency

Latest as of September 2024: 0.126x

Based on the latest financial reports, Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a cash flow conversion efficiency ratio of 0.126x as of September 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL33.37 Million ≈ $747.36K USD) by net assets (TL263.88 Million ≈ $5.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ONCSM days of operational coverage to measure how many days the company can operate on defensive assets alone.

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. - Cash Flow Conversion Efficiency Trend (2020–2023)

This chart illustrates how Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Quoc Cuong Gia Lai JSC VN:QCG	0.004x
Hariom Pipe Industries Limited NSE:HARIOMPIPE	0.063x
Mercuries Data Systems Ltd TW:2427	0.113x
LAUNCH TECH CO. H YC-01 F:LAN	N/A
Cavotec SA ST:CCC	0.011x
Heidelberg Pharma AG F:HPHA	-0.299x
Yao Sheng Electronic Co Ltd TWO:3207	0.005x
RiTdisplay Corp TW:8104	0.022x

Annual Cash Flow Conversion Efficiency for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2023)

The table below shows the annual cash flow conversion efficiency of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. from 2020 to 2023. For the full company profile with market capitalisation and key ratios, see Oncosem Onkolojik Sistemler Sanayi ve Ti market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-12-31	TL231.70 Million ≈ $5.19 Million	TL-38.10 Million ≈ $-853.43K	-0.164x	-169.94%
2022-12-31	TL224.08 Million ≈ $5.02 Million	TL52.69 Million ≈ $1.18 Million	0.235x	-64.14%
2021-12-31	TL78.80 Million ≈ $1.76 Million	TL51.68 Million ≈ $1.16 Million	0.656x	+156.87%
2020-12-31	TL76.02 Million ≈ $1.70 Million	TL19.41 Million ≈ $434.68K	0.255x	--

About Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.

IS:ONCSM Turkey Medical Devices

Market Cap

$139.02 Million

TL6.21 Billion TRY

Market Cap Rank

#18000 Global

#247 in Turkey

Share Price

TL260.25

Change (1 day)

-0.48%

52-Week Range

TL76.85 - TL380.00

All Time High

TL380.00